Akero Therapeutics Inc.

NASDAQ: AKRO · Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
47.30
-4.30%
After-hours: Aug 15, 2025, 05:45 PM EDT

Akero Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.41 -8.09 -19.62 -7.31
PEG Ratio
-0.25 -11.61 28.34 -0.5
PS Ratio
n/a n/a n/a n/a
PB Ratio
2.49 2.29 6.54 4.36
P/FCF Ratio
-8.12 -8.44 -23.09 -9.24
P/OCF Ratio
-8.12 -8.44 -23.09 -9.24
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.05 0.05 0.03 0.01
Quick Ratio
19.38 29.27 18.61 7.70
Current Ratio
19.38 29.27 18.61 7.70
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-61.14 -55.78 -155.83 n/a
Return on Equity
-0.34 -0.28 -0.33 -0.6
Return on Assets
-0.31 -0.26 -0.31 -0.52
Return on Invested Capital
-0.36 -0.31 -0.33 -0.59
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a